1. P805: ALEMTUZUMAB IN RELAPSED SEVERE APLASTIC ANEMIA: LONG-TERM RESULTS OF A PHASE II STUDY. (23rd June 2022) Authors: Aggarwal, N.; Manley, A. L.; Durrani, J.; Shalhoub, R.; Rios, O.; Lotter, J.; Patel, B.; Wu, C.; Young, N.; Groarke, E. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 699 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P832: CLINICAL OUTCOMES AND IMMUNE RESPONSES TO SARS-COV-2 VACCINATION IN PATIENTS WITH SEVERE APLASTIC ANEMIA. (23rd June 2022) Authors: Rajput, R.; Ma, X.; Boswell, K. L.; Gaudinski, M.; Groarke, E. M.; Lotter, J.; Rios, O.; Darden, I.; Wu, C. O.; Koup, R. A.; Young, N. S.; Patel, B. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 726 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗